| [1] |
Wanner IB, Anderson MA, Song B, et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury[J]. J Neurosci, 2013, 33(31): 12870-12886. DOI: 10.1523/jneurosci.2121-13.2013.
|
| [2] |
|
| [3] |
Bayen E, Ruet A, Jourdan C, et al. Lawsuit and traumatic brain injury: the relationship between long-lasting sequelae and financial compensation in litigants. Results from the PariS-TBI study[J]. Front Neurol, 2019, 10: 320. DOI: 10.3389/fneur.2019.00320.
|
| [4] |
Lozano D, Gonzales-Portillo GS, Acosta S, et al. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities[J]. Neuropsychiatr Dis Treat, 2015, 11: 97-106. DOI: 10.2147/ndt.S65815.
|
| [5] |
Simon DW, McGeachy MJ, Bayır H, et al. The far-reaching scope of neuroinflammation after traumatic brain injury[J]. Nat Rev Neurol, 2017, 13(3): 171-191. DOI: 10.1038/nrneurol.2017.13.
|
| [6] |
McKee CA, Lukens JR. Emerging roles for the immune system in traumatic brain injury[J]. Front Immunol, 2016, 7: 556. DOI: 10.3389/fimmu.2016.00556.
|
| [7] |
Donat CK, Scott G, Gentleman SM, et al. Microglial activation in traumatic brain injury[J]. Front Aging Neurosci, 2017, 9: 208. DOI: 10.3389/fnagi.2017.00208.
|
| [8] |
宋鸽,刘晓银,史新宇,等.创伤性脑损伤相关神经炎症的研究进展[J]. 天津医药, 2020, 48(5): 449-454. DOI: 10.11958/20193631. |
| [9] |
Brown GC, Vilalta A, Fricker M. Phagoptosis-cell death by phagocytosis-plays central roles in physiology, host defense and pathology[J]. Curr Mol Med, 2015, 15(9): 842-851. DOI: 10.2174/156652401509151105130628.
|
| [10] |
Rathbone AT, Tharmaradinam S, Jiang S, et al. A review of the neuro- and systemic inflammatory responses in post concussion symptoms: introduction of the "post-inflammatory brain syndrome" PIBS[J]. Brain Behav Immun, 2015, 46: 1-16. DOI: 10.1016/j.bbi.2015.02.009.
|
| [11] |
Collins-Praino LE, Corrigan F. Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?[J]. Brain Behav Immun, 2017, 60: 369-382. DOI: 10.1016/j.bbi.2016.09.027.
|
| [12] |
Malik A, Kanneganti TD. Inflammasome activation and assembly at a glance[J]. J Cell Sci, 2017, 130(23): 3955-3963. DOI: 10.1242/jcs.207365.
|
| [13] |
Bauernfried S, Scherr MJ, Pichlmair A, et al. Human NLRP1 is a sensor for double-stranded RNA[J]. Science, 2021, 371(6528): eabd0811. DOI: 10.1126/science.abd0811.
|
| [14] |
Chavarría-Smith J, Vance RE. The NLRP1 inflammasomes[J]. Immunol Rev, 2015, 265(1): 22-34. DOI: 10.1111/imr.12283.
|
| [15] |
|
| [16] |
Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling[J]. Nat Rev Immunol, 2016, 16(7): 407-420. DOI: 10.1038/nri.2016.58.
|
| [17] |
Sundaram B, Kanneganti TD. Advances in understanding activation and function of the NLRC4 inflammasome[J]. Int J Mol Sci, 2021, 22(3): 1048. DOI: 10.3390/ijms22031048.
|
| [18] |
Ghimire L, Paudel S, Jin L, et al. The NLRP6 inflammasome in health and disease[J]. Mucosal Immunol, 2020, 13(3): 388-398. DOI: 10.1038/s41385-020-0256-z.
|
| [19] |
Adamczak SE, de Rivero Vaccari JP, Dale G, et al. Pyroptotic neuronal cell death mediated by the AIM2 inflammasome[J]. J Cereb Blood Flow Metab, 2014, 34(4): 621-629. DOI: 10.1038/jcbfm.2013.236.
|
| [20] |
Schimmel SJ, Acosta S, Lozano D. Neuroinflammation in traumatic brain injury: a chronic response to an acute injury[J]. Brain Circ, 2017, 3(3): 135-142. DOI: 10.4103/bc.bc_18_17.
|
| [21] |
de Rivero Vaccari JP, Lotocki G, Alonso OF, et al. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury[J]. J Cereb Blood Flow Metab, 2009, 29(7): 1251-1261. DOI: 10.1038/jcbfm.2009.46.
|
| [22] |
Silverman WR, de Rivero Vaccari JP, Locovei S, et al. The pannexin 1 channel activates the inflammasome in neurons and astrocytes[J]. J Biol Chem, 2009, 284(27): 18143-18151. DOI: 10.1074/jbc.M109.004804.
|
| [23] |
Liu HD, Li W, Chen ZR, et al. Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model[J]. Neurochem Res, 2013, 38(10): 2072-2083. DOI: 10.1007/s11064-013-1115-z.
|
| [24] |
Irrera N, Pizzino G, Calò M, et al. Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury[J]. Front Pharmacol, 2017, 8: 459. DOI: 10.3389/fphar.2017.00459.
|
| [25] |
|
| [26] |
Du H, Li CH, Gao RB, et al. Ablation of GSDMD attenuates neurological deficits and neuropathological alterations after traumatic brain injury[J]. Front Cell Neurosci, 2022, 16: 915969. DOI: 10.3389/fncel.2022.915969.
|
| [27] |
Liu W, Chen Y, Meng J, et al. Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo[J]. J Neuroinflammation, 2018, 15(1): 48. DOI: 10.1186/s12974-018-1083-y.
|
| [28] |
Kwan J, Horsfield G, Bryant T, et al. IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke[J]. Exp Gerontol, 2013, 48(9): 960-965. DOI: 10.1016/j.exger.2013.07.003.
|
| [29] |
Cyr B, Hadad R, Keane RW, et al. The role of non-canonical and canonical inflammasomes in inflammaging[J]. Front Mol Neurosci, 2022, 15: 774014. DOI: 10.3389/fnmol.2022.774014.
|
| [30] |
Korley FK, Jain S, Sun X, et al. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study[J]. Lancet Neurol, 2022, 21(9): 803-813. DOI: 10.1016/s1474-4422(22)00256-3.
|
| [31] |
O'Brien WT, Pham L, Symons GF, et al. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target[J]. J Neuroinflammation, 2020, 17(1): 104. DOI: 10.1186/s12974-020-01778-5.
|
| [32] |
Pérez-Bárcena J, Crespí C, Frontera G, et al. Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome[J]. J Neurosurg, 2020, 134(5): 1644-1649. DOI: 10.3171/2020.2.Jns193079.
|
| [33] |
Kerr N, Lee SW, Perez-Barcena J, et al. Inflammasome proteins as biomarkers of traumatic brain injury[J]. PLoS One, 2018, 13(12): e0210128. DOI: 10.1371/journal.pone.0210128.
|
| [34] |
Johnson NH, Hadad R, Taylor RR, et al. Inflammatory biomarkers of traumatic brain injury[J]. Pharmaceuticals (Basel), 2022, 15(6): 660. DOI: 10.3390/ph15060660.
|
| [35] |
|
| [36] |
de Rivero Vaccari JP, Dietrich WD, Keane RW. Therapeutics targeting the inflammasome after central nervous system injury[J]. Transl Res, 2016, 167(1): 35-45. DOI: 10.1016/j.trsl.2015.05.003.
|
| [37] |
|
| [38] |
Zahid A, Li B, Kombe AJK, et al. Pharmacological inhibitors of the NLRP3 inflammasome[J]. Front Immunol, 2019, 10: 2538. DOI: 10.3389/fimmu.2019.02538.
|
| [39] |
Coll RC, Hill JR, Day CJ, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition[J]. Nat Chem Biol, 2019, 15(6): 556-559. DOI: 10.1038/s41589-019-0277-7.
|
| [40] |
Dempsey C, Rubio Araiz A, Bryson KJ, et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice[J]. Brain Behav Immun, 2017, 61: 306-316. DOI: 10.1016/j.bbi.2016.12.014.
|
| [41] |
Sun Z, Nyanzu M, Yang S, et al. VX765 attenuates pyroptosis and HMGB1/TLR4/NF-κB pathways to improve functional outcomes in TBI mice[J]. Oxid Med Cell Longev, 2020, 2020: 7879629. DOI: 10.1155/2020/7879629.
|
| [42] |
Kerr NA, de Rivero Vaccari JP, Abbassi S, et al. Traumatic brain injury-induced acute lung injury: evidence for activation and inhibition of a neural-respiratory-inflammasome axis[J]. J Neurotrauma, 2018, 35(17): 2067-2076. DOI: 10.1089/neu.2017.5430.
|
| [43] |
Lee SW, de Rivero Vaccari JP, Truettner JS, et al. The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury[J]. J Neuroinflammation, 2019, 16(1): 27. DOI: 10.1186/s12974-019-1423-6.
|